The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Acorda Therapeutics, Inc(NASDAQ:ACOR) 
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol d...
Website: http://www.acorda.com
Founded: 1995
Full Time Employees: 344
Sector: Healthcare
Industry: Biotechnology
Acorda Therapeutics Days Payable Outstanding ttm (DPO)
Acorda Therapeutics Days Receivable Outstanding ttm (DSO)
Acorda Therapeutics Days Inventory Outstanding ttm (DIO)
Acorda Therapeutics Op Cashflow Per Share ttm
Acorda Therapeutics Free Cashflow Per Share ttm
Acorda Therapeutics Cash Per Share ttm
Acorda Therapeutics P/S ratio ttm
Acorda Therapeutics (GAAP) P/E ratio ttm
Acorda Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.